A Short-Term Resistance Training Circuit Improved Antioxidants in Sedentary Adults with Down Syndrome

• Published in: Oxidative medicine and cellular longevity Vol. 2021; no. 1; p. 8811153
• Main Authors: Rosety-Rodriguez, M., Bernardi, M., Elosegui, S., Rosety, I., Diaz, A. J., Rosety, M. A., Brenes, F., Oliva-Pascual-Vaca, A., Alvero-Cruz, J. R., Ordonez, F. J.
• Format: Journal Article
• Language: English
• Published: United States Hindawi 2021; Hindawi Limited
• Subjects: Antioxidants; Body mass index; Community support; Cytochrome; Exercise; Plasma; Proteins; Sedentary behavior; Strength training; Vitamin E; United Kingdom > UK; United States > US; Spain
• ISSN: 1942-0900; 1942-0994
• DOI: 10.1155/2021/8811153

Previous studies have found aerobic training improved oxidative damage in people with Down syndrome (DS). However, there is a lack of information regarding the influence of resistance training on redox imbalance in this population. Accordingly, this study was conducted to determine the effect of resistance training (RT) on antioxidant defence system in sedentary adults with DS. Thirty-six male adults with DS were recruited through different community support groups. Eighteen were randomly assigned to perform a circuit RT program with 6 stations, 3 days/week for 12 weeks. Plasma total antioxidant status (TAS), reduced glutathione (GHS), ascorbate, serum α-tocopherol, and erythrocyte glutathione reductase activity were assessed. Plasma malondialdehyde (MDA) and carbonyl groups (CG) were assessed as markers of oxidative damage. Muscle strength was also measured. Dynamic torque of knee extensors and flexors as well as maximal handgrip strength was significantly improved after the completion of the training program. Plasma levels of TAS and erythrocyte glutathione reductase (GR) activity were significantly increased. Conversely, MDA and CG levels were significantly reduced. It was concluded RT improved antioxidant defence system and reduced oxidative damage in adults with DS. Further, long-term studies are required to determine whether the increased antioxidant system may improve clinical outcomes of adults with DS.